ArticleThe pharmacogenomics journal2024

Polygenic scores for cardiovascular risk factors improve estimation of clinical outcomes in CCB treatment compared to pharmacogenetic variants alone.

Deniz Türkmen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.